Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia

By Cadeddu J.A.   Pearson J.D.   Lee B.R.   Landis P.   Partin A.W.   Epstein J.I.   Carter H.B.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 795-800

Elsevier

Access to resources Recommend Favorite

Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin

By Roehrborn C.G.   Oesterling J.E.   Olson P.J.   Padley R.J.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 556-561

Elsevier

Access to resources Recommend Favorite

Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia - the establishment of appropriate reference ranges for concentrations and ratios

By Cetinkaya M.   Ulusoy E.   Aki T.   Kosan M.   Kundak c.   Aydos M.M.   Gokkaya S.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 118-120

Elsevier

Access to resources Recommend Favorite

Effects of Chronic Bacterial Prostatitis on Prostate Specific Antigen Levels Total and Free in Patients with Benign Prostatic Hyperplasia and Prostate Cancer

By Battikhi Mohammed   Ismail Hussein   Battikhi Qusey  

International Urology and Nephrology, Vol. 38, Iss. 1, 2006-02 ,pp. : 21-26

Springer Publishing Company

Access to resources Recommend Favorite

Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia

By Lowe F.C.   McDaniel R.L.   Chmiel J.J.   Hillman A.L.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 477-483

Elsevier

Access to resources Recommend Favorite